Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1999 Dec;81(7):1162–1164. doi: 10.1038/sj.bjc.6690824

Expression of testicular genes in haematological malignancies

S H Lim 1, S Austin 1, E Owen-Jones 1, L Robinson 1
PMCID: PMC2374325  PMID: 10584877

Abstract

The gene expression of a new group of tumour antigens known as cancer/testis (CT) antigens is now well-recognized in some solid tumours. However, their expression in haematological malignancies remained unclear. In this study, we have used reverse transcription polymerase chain reaction and Southern blot analysis to examine the presence of transcripts for the three CT antigens, NY-ESO-1, SSX2 and SCP1 in haematological malignant cells. We found that transcripts for SCP1 could be detected in 10% of myeloma, 5.7% of acute myeloid leukaemia and 23% of chronic myeloid leukaemia. In contrast, NY-ESO-1 and SSX2 were not detected in any of the 107 tumour samples. © 1999 Cancer Research Campaign

Keywords: CT antigens, leukaemia, myeloma

Full Text

The Full Text of this article is available as a PDF (49.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chen Y. T., Scanlan M. J., Sahin U., Türeci O., Gure A. O., Tsang S., Williamson B., Stockert E., Pfreundschuh M., Old L. J. A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc Natl Acad Sci U S A. 1997 Mar 4;94(5):1914–1918. doi: 10.1073/pnas.94.5.1914. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Choudhury A., Gajewski J. L., Liang J. C., Popat U., Claxton D. F., Kliche K. O., Andreeff M., Champlin R. E. Use of leukemic dendritic cells for the generation of antileukemic cellular cytotoxicity against Philadelphia chromosome-positive chronic myelogenous leukemia. Blood. 1997 Feb 15;89(4):1133–1142. [PubMed] [Google Scholar]
  3. Coleman S., Throp D., Fisher J., Bailey-Wood R., Lim S. H. Cytokine enhancement of immunogenicity in chronic myeloid leukaemia. Leukemia. 1997 Dec;11(12):2055–2059. doi: 10.1038/sj.leu.2400858. [DOI] [PubMed] [Google Scholar]
  4. Gure A. O., Türeci O., Sahin U., Tsang S., Scanlan M. J., Jäger E., Knuth A., Pfreundschuh M., Old L. J., Chen Y. T. SSX: a multigene family with several members transcribed in normal testis and human cancer. Int J Cancer. 1997 Sep 17;72(6):965–971. doi: 10.1002/(sici)1097-0215(19970917)72:6<965::aid-ijc8>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
  5. Lim S. H., Coleman S., Bailey-Wood R. In vitro cytokine-primed leukaemia cells induce in vivo T cell responsiveness in chronic myeloid leukaemia. Bone Marrow Transplant. 1998 Dec;22(12):1185–1190. doi: 10.1038/sj.bmt.1701511. [DOI] [PubMed] [Google Scholar]
  6. Old L. J., Chen Y. T. New paths in human cancer serology. J Exp Med. 1998 Apr 20;187(8):1163–1167. doi: 10.1084/jem.187.8.1163. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Pawelec G., Max H., Halder T., Bruserud O., Merl A., da Silva P., Kalbacher H. BCR/ABL leukemia oncogene fusion peptides selectively bind to certain HLA-DR alleles and can be recognized by T cells found at low frequency in the repertoire of normal donors. Blood. 1996 Sep 15;88(6):2118–2124. [PubMed] [Google Scholar]
  8. Sahin U., Türeci O., Schmitt H., Cochlovius B., Johannes T., Schmits R., Stenner F., Luo G., Schobert I., Pfreundschuh M. Human neoplasms elicit multiple specific immune responses in the autologous host. Proc Natl Acad Sci U S A. 1995 Dec 5;92(25):11810–11813. doi: 10.1073/pnas.92.25.11810. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Türeci O., Chen Y. T., Sahin U., Güre A. O., Zwick C., Villena C., Tsang S., Seitz G., Old L. J., Pfreundschuh M. Expression of SSX genes in human tumors. Int J Cancer. 1998 Jul 3;77(1):19–23. doi: 10.1002/(sici)1097-0215(19980703)77:1<19::aid-ijc4>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
  10. Türeci O., Sahin U., Zwick C., Koslowski M., Seitz G., Pfreundschuh M. Identification of a meiosis-specific protein as a member of the class of cancer/testis antigens. Proc Natl Acad Sci U S A. 1998 Apr 28;95(9):5211–5216. doi: 10.1073/pnas.95.9.5211. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Van den Eynde B. J., van der Bruggen P. T cell defined tumor antigens. Curr Opin Immunol. 1997 Oct;9(5):684–693. doi: 10.1016/s0952-7915(97)80050-7. [DOI] [PubMed] [Google Scholar]
  12. Wen Y. J., Lim S. H. T cells recognize the VH complementarity-determining region 3 of the idiotypic protein of B cell non-Hodgkin's lymphoma. Eur J Immunol. 1997 Apr;27(4):1043–1047. doi: 10.1002/eji.1830270435. [DOI] [PubMed] [Google Scholar]
  13. Wen Y. J., Ling M., Bailey-Wood R., Lim S. H. Idiotypic protein-pulsed adherent peripheral blood mononuclear cell-derived dendritic cells prime immune system in multiple myeloma. Clin Cancer Res. 1998 Apr;4(4):957–962. [PubMed] [Google Scholar]
  14. Wen Y. J., Ling M., Lim S. H. Immunogenicity and cross-reactivity with idiotypic IgA of VH CDR3 peptide in multiple myeloma. Br J Haematol. 1998 Mar;100(3):464–468. doi: 10.1046/j.1365-2141.1998.00592.x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES